A randomized trial of diet and physical activity in women treated for stage II–IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study

Contemporary Clinical Trials

Volumn 49, Issue , 2016, Pages 181-189

  Thomson, Cynthia A ^a   Crane, Tracy E ^a   Miller, Austin ^b   Garcia, David O ^a   Basen Engquist, Karen ^c   Alberts, David S ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b NRG Oncology Gynecologic Oncology Group   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Behavior; Cancer survival; Clinical trial; Diet; Ovarian cancer; Physical activity

Indexed keywords

INSULIN; LIPID;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BLOOD SAMPLING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVOR; CANCER THERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; DIET THERAPY; E-MAIL; FEMALE; HIGH FIBER DIET; HUMAN; LIFESTYLE MODIFICATION; LOW FAT DIET; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OVARY CANCER; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; TELOMERE HOMEOSTASIS; VEGETABLE; VERY ELDERLY; DIETARY FIBER; DISEASE FREE SURVIVAL; KINESIOTHERAPY; LIFESTYLE; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PATIENT COMPLIANCE; PROCEDURES; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CANCER SURVIVORS; DIET THERAPY; DIET, FAT-RESTRICTED; DIETARY FIBER; DISEASE-FREE SURVIVAL; EXERCISE THERAPY; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; QUALITY OF LIFE; VEGETABLES; YOUNG ADULT;

EID: 84979072564     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2016.07.005     Document Type: Article

References (73)

1. [1] DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., Alteri, R., Robbins, A.S., Jemal, A., Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 64:4 (2014), 252–271.
2. [2] Baldwin, L.A., Huang, B., Miller, R.W., Tucker, T., Goodrich, S.T., Podzielinski, I., DeSimone, C.P., Ueland, F.R., van Nagell, J.R., Seamon, L.G., Ten-year relative survival for epithelial ovarian cancer. Obstet. Gynecol. 120:3 (2012), 612–618.
3. [3] Lu, Y., Cuellar-Partida, G., Painter, J.N., Nyholt, D.R., S. Australian Ovarian Cancer, C. International Endogene, Morris, A.P., Fasching, P.A., Hein, A., Burghaus, S., Beckmann, M.W., Lambrechts, D., Van Nieuwenhuysen, E., Vergote, I., Vanderstichele, A., Doherty, J.A., Rossing, M.A., Wicklund, K.G., Chang-Claude, J., Eilber, U., Rudolph, A., Wang-Gohrke, S., Goodman, M.T., Bogdanova, N., Dork, T., Durst, M., Hillemanns, P., Runnebaum, I.B., Antonenkova, N., Butzow, R., Leminen, A., Nevanlinna, H., Pelttari, L.M., Edwards, R.P., Kelley, J.L., Modugno, F., Moysich, K.B., Ness, R.B., Cannioto, R., Hogdall, E., Jensen, A., Giles, G.G., Bruinsma, F., Kjaer, S.K., Hildebrandt, M.A., Liang, D., Lu, K.H., Wu, X., Bisogna, M., Dao, F., Levine, D.A., Cramer, D.W., Terry, K.L., Tworoger, S.S., Missmer, S., Bjorge, L., Salvesen, H.B., Kopperud, R.K., Bischof, K., Aben, K.K., Kiemeney, L.A., Massuger, L.F., Brooks-Wilson, A., Olson, S.H., McGuire, V., Rothstein, J.H., Sieh, W., Whittemore, A.S., Cook, L.S., Le, N.D., Gilks, C.B., Gronwald, J., Jakubowska, A., Lubinski, J., Gawelko, J., Song, H., Tyrer, J.P., Wentzensen, N., Brinton, L., Trabert, B., Lissowska, J., McLaughlin, J.R., Narod, S.A., Phelan, C., Anton-Culver, H., Ziogas, A., Eccles, D., Gayther, S.A., Gentry-Maharaj, A., Menon, U., Ramus, S.J., Wu, A.H., Dansonka-Mieszkowska, A., Kupryjanczyk, J., Timorek, A., Szafron, L., Cunningham, J.M., Fridley, B.L., Winham, S.J., Bandera, E.V., Poole, E.M., Morgan, T.K., Risch, H.A., Goode, E.L., Schildkraut, J.M., Webb, P.M., Pearce, C.L., Berchuck, A., Pharoah, P.D., Montgomery, G.W., Zondervan, K.T., Chenevix-Trench, G., McGregor, S., Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum. Mol. Genet., 2015.
4. [4] Toss, A., Tomasello, C., Razzaboni, E., Contu, G., Grandi, G., Cagnacci, A., Schilder, R.J., Cortesi, L., Hereditary ovarian cancer: not only BRCA 1 and 2 genes. BioMed Res. Int., 2015, 2015, 341723.
5. [5] Sueblinvong, T., Carney, M.E., Current understanding of risk factors for ovarian cancer. Curr. Treat. Options in Oncol. 10:1–2 (2009), 67–81.
6. [6] Crane, T.E., Khulpateea, B.R., Alberts, D.S., Basen-Engquist, K., Thomson, C.A., Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol. Biomark. Prev. 23:2 (2014), 255–273 a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
7. [7] Dolecek, T.A., McCarthy, B.J., Joslin, C.E., Peterson, C.E., Kim, S., Freels, S.A., Davis, F.G., Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer. J. Am. Diet. Assoc. 110:3 (2010), 369–382.
8. [8] Thomson, C.A., E.C., T., Wertheim, B.C., Neuhouser, M.L., Li, W., Snetselaar, L.G., Basen-Engquist, K.M., Zhou, Y., Irwin, M.L., Diet quality and survival after ovarian cancer: results from the Women's Health Initiative. J. Natl. Cancer Inst., 106(11), 2014.
9. [9] Kruijsen-Jaarsma, M., Revesz, D., Bierings, M.B., Buffart, L.M., Takken, T., Effects of exercise on immune function in patients with cancer: a systematic review. Exerc. Immunol. Rev. 19 (2013), 120–143.
10. [10] McTiernan, A., Tworoger, S.S., Rajan, K.B., Yasui, Y., Sorenson, B., Ulrich, C.M., Chubak, J., Stanczyk, F.Z., Bowen, D., Irwin, M.L., Rudolph, R.E., Potter, J.D., Schwartz, R.S., Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol. Biomark. Prev. 13:7 (2004), 1099–1105 a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
11. [11] Bertone, E.R., Willett, W.C., Rosner, B.A., Hunter, D.J., Fuchs, C.S., Speizer, F.E., Colditz, G.A., Hankinson, S.E., S. Nurses' Health, Prospective study of recreational physical activity and ovarian cancer. Journal of the National Cancer Institute 93:12 (2001), 942–948.
12. [12] Rock, C.L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K.S., Schwartz, A.L., Bandera, E.V., Hamilton, K.K., Grant, B., McCullough, M., Byers, T., Gansler, T., Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 62:4 (2012), 243–274.
13. [13] Rieck, G., Fiander, A., The effect of lifestyle factors on gynaecological cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 20:2 (2006), 227–251.
14. [14] McTiernan, A., Intervention studies in exercise and cancer prevention. Med. Sci. Sports Exerc. 35:11 (2003), 1841–1845.
15. [15] Zhou, Y., Chlebowski, R., LaMonte, M.J., Bea, J.W., Qi, L., Wallace, R., Lavasani, S., Walsh, B.W., Anderson, G., Vitolins, M., Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: Results from the Women's Health Initiative. Gynecol. Oncol. 133:1 (2014), 4–10.
16. [16] Bandura, A., Social Foundations of Thought and Action: a Social Cognitive Theory. 1986, Prentice-Hall, Inc.
17. [17] Pierce, J.P., Faerber, S., Wright, F.A., Rock, C.L., Newman, V., Flatt, S.W., Kealey, S., Jones, V.E., Caan, B.J., Gold, E.B., Haan, M., Hollenbach, K.A., Jones, L., Marshall, J.R., Ritenbaugh, C., Stefanick, M.L., Thomson, C., Wasserman, L., Natarajan, L., Thomas, R.G., Gilpin, E.A., A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control. Clin. Trials 23:6 (2002), 728–756.
18. [18] Chlebowski, R., Blackburn, G., Elashoff, R., Thomson, C., Goodman, M., Shapiro, A., Giuliano, A., Karanja, N., Hoy, M., Nixon, D., Dietary fat reduction in postmenopausal women with primary breast cancer: phase III Women's Intervention Nutrition Study (WINS). Proc. Annu. Meet. Am. Soc. Clin. Oncol., 2005, 10.
19. [19] Moyers, T., Martin, T., Manuel, J., Miller, W., Ernst, D., Revised Global Scales: Motivational Interviewing Treatment Integrity 3.1. 1 (MITI 3.1. 1). Unpublished Manuscript, 2010, Center on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque.
20. [20] Bandura, A., McClelland, D.C., Social learning theory., 1977.
21. [21] Gil, K.M., von Gruenigen, V.E., Physical activity and gynecologic cancer survivorship. Physical Activity and Cancer, 2010, Springer, 305–315.
22. [22] Midtgaard, J., Theoretical and practical outline of the Copenhagen PACT narrative-based exercise counselling manual to promote physical activity in post-therapy cancer survivors. Acta Oncol. 52:2 (2013), 303–309.
23. [23] Rotter, J.B., Generalized expectancies for internal versus external control of reinforcement. Psychol. Monogr. Gen. Appl., 80(1), 1966, 1.
24. [24] Ajzen, I., The theory of planned behavior. Org. Behav. Hum. Process. 50 (1991), 179–211.
25. [25] Kushi, L.H., Doyle, C., McCullough, M., Rock, C.L., Demark-Wahnefried, W., Bandera, E.V., Gapstur, S., Patel, A.V., Andrews, K., Gansler, T., American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J. Clin. 62:1 (2012), 30–67.
26. [26] Nagle, C.M., Purdie, D.M., Webb, P.M., Green, A., Harvey, P.W., Bain, C.J., Dietary influences on survival after ovarian cancer. Int. J. Cancer 106:2 (2003), 264–269.
27. [27] Paxton, R.J., Garcia-Prieto, C., Berglund, M., Hernandez, M., Hajek, R.A., Handy, B., Brown, J., Jones, L.A., A randomized parallel-group dietary study for stages II–IV ovarian cancer survivors. Gynecol. Oncol. 124:3 (2012), 410–416.
28. [28] Tian, Q., Miller, E.G., Ahmad, H., Tang, L., Patil, B.S., Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr. Cancer 40:2 (2001), 180–184.
29. [29] el, S.A.A., Zhu, Q., Barakat, B.M., Wani, G., Zhao, Q., El-Mahdy, M.A., Wani, A.A., Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res. 69:23 (2009), 8910–8917.
30. [30] Edefonti, V., Decarli, A., La Vecchia, C., Bosetti, C., Randi, G., Franceschi, S., Dal Maso, L., Ferraroni, M., Nutrient dietary patterns and the risk of breast and ovarian cancers. Int. J. Cancer 122:3 (2008), 609–613.
31. [31] Prentice, R.L., Thomson, C.A., Caan, B., Hubbell, F.A., Anderson, G.L., Beresford, S.A., Pettinger, M., Lane, D.S., Lessin, L., Yasmeen, S., Singh, B., Khandekar, J., Shikany, J.M., Satterfield, S., Chlebowski, R.T., Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J. Natl. Cancer Inst. 99:20 (2007), 1534–1543.
32. [32] Kolahdooz, F., Ibiebele, T.I., van der Pols, J.C., Webb, P.M., Dietary patterns and ovarian cancer risk. Am. J. Clin. Nutr. 89:1 (2009), 297–304.
33. [33] Edefonti, V., Randi, G., Decarli, A., La Vecchia, C., Bosetti, C., Franceschi, S., Dal Maso, L., Ferraroni, M., Clustering dietary habits and the risk of breast and ovarian cancers. Ann. Oncol: Off. J. Eur. Soc. Med. Oncol./ESMO 20:3 (2009), 581–590.
34. [34] Stevinson, C., Capstick, V., Schepansky, A., Tonkin, K., Vallance, J.K., Ladha, A.B., Steed, H., Faught, W., Courneya, K.S., Physical activity preferences of ovarian cancer survivors. Psychooncology 18:4 (2009), 422–428.
35. [35] Cust, A.E., Physical activity and gynecologic cancer prevention. Recent Results Cancer Res. 186 (2011), 159–185.
36. [36] Lynch, B.M., Dunstan, D.W., Vallance, J.K., Owen, N., Don't take cancer sitting down: a new survivorship research agenda. Cancer 119:11 (2013), 1928–1935.
37. [37] Zhang, M., Xie, X., Lee, A.H., Binns, C.W., Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes Control 15:1 (2004), 83–89.
38. [38] Zheng, W., Shu, X.O., McLaughlin, J.K., Chow, W.H., Gao, Y.T., Blot, W.J., Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in Shanghai. Cancer 71:11 (1993), 3620–3624.
39. [39] Vallance, J.K., Courneya, K.S., Plotnikoff, R.C., Yasui, Y., Mackey, J.R., Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 25:17 (2007), 2352–2359.
40. [40] Harris, T., Kerry, S.M., Victor, C.R., Shah, S.M., Iliffe, S., Ussher, M., Ekelund, U., Fox-Rushby, J., Whincup, P., David, L., Brewin, D., Ibison, J., DeWilde, S., Limb, E., Anokye, N., Furness, C., Howard, E., Dale, R., Cook, D.G., PACE-UP (pedometer and consultation evaluation–UP)–a pedometer-based walking intervention with and without practice nurse support in primary care patients aged 45–75 years: study protocol for a randomised controlled trial. Trials, 14, 2013, 418.
41. [41] Schmitz, K.H., Courneya, K.S., Matthews, C., Demark-Wahnefried, W., Galvao, D.A., Pinto, B.M., Irwin, M.L., Wolin, K.Y., Segal, R.J., Lucia, A., Schneider, C.M., von Gruenigen, V.E., Schwartz, A.L., M. American College of Sports, American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42:7 (2010), 1409–1426.
42. [42] Hays, R.D., Sherbourne, C.D., Mazel, R.M., The rand 36-item health survey 1.0. Health Econ. 2:3 (1993), 217–227.
43. [43] Wiklund, I., Fullerton, S., Hawkey, C., Jones, R., Longstreth, G., Mayer, E., Peacock, R., Wilson, I., Naesdal, J., An irritable bowel syndrome-specific symptom questionnaire: development and validation., 2009.
44. [44] Martínez, M.E., Marshall, J.R., Graver, E., Whitacre, R.C., Woolf, K., Ritenbaugh, C., Alberts, D.S., Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol. Biomark. Prev. 8:10 (1999), 941–946.
45. [45] Thomson, C.A., Giuliano, A., Rock, C.L., Ritenbaugh, C.K., Flatt, S.W., Faerber, S., Newman, V., Caan, B., Graver, E., Hartz, V., Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am. J. Epidemiol. 157:8 (2003), 754–762.
46. [46] Neuhouser, M.L., Di, C., Tinker, L.F., Thomson, C., Sternfeld, B., Mossavar-Rahmani, Y., Stefanick, M.L., Sims, S., Curb, J.D., Lamonte, M., Seguin, R., Johnson, K.C., Prentice, R.L., Physical activity assessment: biomarkers and self-report of activity-related energy expenditure in the WHI. Am. J. Epidemiol. 177:6 (2013), 576–585.
47. [47] Ainsworth, B.E., Haskell, W.L., Herrmann, S.D., Meckes, N., Bassett, D.R. Jr., Tudor-Locke, C., Greer, J.L., Vezina, J., Whitt-Glover, M.C., Leon, A.S., 2011 Compendium of Physical Activities: a second update of codes and MET values. Med. Sci. Sports Exerc. 43:8 (2011), 1575–1581.
48. [48] Buysse, D.J., Reynolds, C.F. 3rd, Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28:2 (1989), 193–213.
49. [49] Clark, B.K., Winkler, E., Healy, G.N., Gardiner, P.G., Dunstan, D.W., Owen, N., Reeves, M.M., Adults' past-day recall of sedentary time: reliability, validity, and responsiveness. Med. Sci. Sports Exerc. 45:6 (2013), 1198–1207.
50. [50] Rogers, L.Q., Objective monitoring of physical activity after a cancer diagnosis: challenges and opportunities for enhancing cancer control. Phys. Ther. Rev. 15:3 (2010), 224–237.
51. [51] Broderick, J.M., Ryan, J., O'Donnell, D.M., Hussey, J., A guide to assessing physical activity using accelerometry in cancer patients. Support. Care Cancer: Off. J. Multinatl. Assoc. Support. Care Cancer, 2014.
52. [52] Shirona, E.J., Cook, N.R., Manson, J.E., Buring, J.E., Rimm, E.B., Lee, I.M., Comparison of self-reported and accelerometer-assessed physical activity in older women. PLOS One, 10(12), 2015, e0145950.
53. [53] Tudor-Locke, C., A catalog of rules, variables, and definitions applied to accelerometer data in the National Health and Nutrition Examination Survey, 2003–2006. Prev. Chronic Dis., 9, 2012.
54. [54] Freedson, P.S., Melanson, E.L., Sirard, J.R., Calibration of the Computer Science and Applications, Inc.-.accelerometer. Med. Sci. Sports Exerc., 30(5), 1997.
55. [55] Troiano, R.P., Berrigan, D., Dodd, K.W., Masse, L.C., Tilert, T., McDowell, M., Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 40:1 (2008), 181–188.
56. [56] Jovanovic, J., Baum, G., Hughes, D.C., McFalls, K.N., Carmack Taylor, C., Basen-Engquist, K., Use of actigraphs and self reports to measure bouts and intensity of exercise in cancer survivors. Med. Sci. Sports Exerc., 39(5), 2007, S62.
57. [57] Celis-Morales, C.A., Perez-Bravo, F., Ibanez, L., Salas, C., Bailey, M.E., Gill, J.M., Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PLoS One, 7(5), 2012, e36345.
58. [58] Swartz, A.M., Strath, S.J., Bassett, D.R. Jr., O'Brien, W.L., King, G.A., Ainsworth, B.E., Estimation of energy expenditure using CSA, Inc. accelerometer hip and wrist sites. Med. Sci. Sports Exerc. 32:Suppl (2000), S450–S456.
59. [59] Hendelman, D., Miller, K., Bagget, C., Debold, E., Freedson, P., Validity of accelerometry for the assessment of moderate intensity physical activity in the field. Med. Sci. Sports Exerc. 32:Suppl (2000), S442–S449.
60. [60] Rock, C.L., Flatt, S.W., Natarajan, L., Thomson, C.A., Bardwell, W.A., Newman, V.A., Hollenbach, K.A., Jones, L., Caan, B.J., Pierce, J.P., Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 23:27 (2005), 6631–6638.
61. [61] Torng, P.L., Lee, Y.C., Huang, C.Y., Ye, J.H., Lin, Y.S., Chu, Y.W., Huang, S.C., Cohen, P., Wu, C.W., Lin, C.T., Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene 27:15 (2008), 2137–2147.
62. [62] Dijkgraaf, E.M., Welters, M.J., Nortier, J.W., van der Burg, S.H., Kroep, J.R., Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer. Curr. Pharm. Des. 18:25 (2012), 3816–3827.
63. [63] Lo, C.W., Chen, M.W., Hsiao, M., Wang, S., Chen, C.A., Hsiao, S.M., Chang, J.S., Lai, T.C., Rose-John, S., Kuo, M.L., Wei, L.H., IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res. 71:2 (2011), 424–434.
64. [64] Guo, Y., Xu, F., Lu, T., Duan, Z., Zhang, Z., Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat. Rev. 38:7 (2012), 904–910.
65. [65] Klopp, A.H., Zhang, Y., Solley, T., Amaya-Manzanares, F., Marini, F., Andreeff, M., Debeb, B., Woodward, W., Schmandt, R., Broaddus, R., Lu, K., Kolonin, M.G., Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 18:3 (2012), 771–782.
66. [66] Frisasncho, A.R., Anthropometric Standards an Interactive Nutritional Reference of Body Size and Body Composition for Children and Adults. 2008, The University of Michigan Press, Ann Arbor, MI.
67. [67] Rubinstein, L.V., Gail, M.H., Santner, T.J., Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J. Chronic Dis. 34:9–10 (1981), 469–479.
68. [68] O'Brien, P.C., Fleming, T.R., A multiple testing procedure for clinical trials. Biometrics 35:3 (1979), 549–556.
69. [69] Nutrition and physical activity guidelines for cancer survivors. CA: a cancer journal for clinicians, 62(4), 2012, 275–276.
70. [70] Thomson, C.A., Harris, R.B., Craft, N.E., Hakim, I.A., A cross-sectional analysis demonstrated the healthy volunteer effect in smokers. J. Clin. Epidemiol. 58:4 (2005), 378–382.
71. [71] Pierce, J.P., Natarajan, L., Caan, B.J., Parker, B.A., Greenberg, E.R., Flatt, S.W., Rock, C.L., Kealey, S., Al-Delaimy, W.K., Bardwell, W.A., Carlson, R.W., Emond, J.A., Faerber, S., Gold, E.B., Hajek, R.A., Hollenbach, K., Jones, L.A., Karanja, N., Madlensky, L., Marshall, J., Newman, V.A., Ritenbaugh, C., Thomson, C.A., Wasserman, L., Stefanick, M.L., Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298:3 (2007), 289–298.
72. [72] Hennessy, B.T., Coleman, R.L., Markman, M., Ovarian cancer. Lancet 374:9698 (2009), 1371–1382.
73. [73] Tunca, J.C., Buchler, D.A., Mack, E.A., Ruzicka, F.F., Crowley, J.J., Carr, W.F., The management of ovarian-cancer-caused bowel obstruction. Gynecol. Oncol. 12:2 (1981), 186–192.